Contraception in Medically Complex Adolescents and Young Adults.
adolescent
chronic illness
contraception
sexual health
young adult
Journal
Open access journal of contraception
ISSN: 1179-1527
Titre abrégé: Open Access J Contracept
Pays: New Zealand
ID NLM: 101700100
Informations de publication
Date de publication:
2024
2024
Historique:
received:
27
09
2023
accepted:
29
02
2024
medline:
30
5
2024
pubmed:
30
5
2024
entrez:
30
5
2024
Statut:
epublish
Résumé
Contraception is a significant part of comprehensive sexual and reproductive health (SRH) care for adolescents and young adults (AYA). While providers may assume that AYA with chronic illness are not sexually active, studies have shown that there are no differences in their sexual practices compared to their counterparts without an illness. This assumption may result in less SRH screening, preventative services, and counseling by providers resulting in decreased basic sexual knowledge, increased risk of unplanned pregnancy, and other health disparities. Sexually active AYA with medical complexity are particularly in need of contraception for a variety of reasons. A better understanding of the complexities around contraception counseling can help increase utilization rates, improve shared-decision making around family planning, and reduce the stigma around sexual health counseling in this population. We have included three sections. First, a general overview of contraception methods. Next, an overview of contraceptive methods currently available, their efficacy, and medical eligibility criteria for their use in AYA who have certain characteristics or medical conditions. Finally, cases adapted from real clinical scenarios to highlight specific recommendations for contraception in AYA women living HIV, autoimmune conditions, and those who have received a solid organ transplant. This information will help providers to consider the multiple factors that influence contraception decision-making (including clinical status, thrombosis risk, medication interactions, safety), and optimize care for AYA living with chronic illness.
Identifiants
pubmed: 38812474
doi: 10.2147/OAJC.S424068
pii: 424068
pmc: PMC11134286
doi:
Types de publication
Journal Article
Langues
eng
Pagination
69-83Informations de copyright
© 2024 Addison et al.
Déclaration de conflit d'intérêts
Jessica Addison and Areej Hassan are co-first authors for this study. Dr Areej Hassan is a nexplanon trainer for FDA mandated device training with health care providers. Dr Amy DiVasta is an investigator for the initiated research for a QI project with grant received from Organon. All authors report no other potential conflicts of interest for this work.